Sinopharm's BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Sinopharm's BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2.
Authors: Abdelhafiz AS; Department of Clinical Pathology, National Cancer Institute, Cairo University, Kasr Al-Aini Street, El-Khalig Square, Cairo 11796, Egypt., Ali A; Department of Pulmonary Medicine, Abbassia Chest Hospital, MOH, Cairo 11517, Egypt.; Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China., Kamel MM; Department of Clinical Pathology, National Cancer Institute, Cairo University, Kasr Al-Aini Street, El-Khalig Square, Cairo 11796, Egypt., Ahmed EH; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut 71515, Egypt., Sayed DM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut 71515, Egypt., Bakry RM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut 71515, Egypt.
Source: Vaccines [Vaccines (Basel)] 2022 Sep 03; Vol. 10 (9). Date of Electronic Publication: 2022 Sep 03.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines10091462